Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Role of alpha-receptors in estrogen-induced vasodilation in nonpregnant sheep

Role of alpha-receptors in estrogen-induced vasodilation in nonpregnant sheep attractive. However, only equivocal support for such a mechanism presently exists. For example, decreased tisH344,1985.-Estradiol-17p (E2) producesvasodilation in sev- sue concentrations of a-receptors have been reported in eral systemicvascular beds,but most extensively in the non- the presence of estrogen (8,X), but in several studies an pregnant uterus. It has been postulated that E2 induces this increase in a-receptors has been noted (14, 15, 20). vasodilation via blockade of vascular cu-adrenergic receptors. Furthermore, estrogen treatment has been shown both This hypothesis was tested in six chronically instrumented, nonpregnant sheep by comparing the systemic and uterine to increase (3) and decrease (10) tissue levels of cateresults have also come from in hemodynamicresponses intravenous E2, to an cu-adrenergic cholamines. Conflicting to receptor blocker, phentolamine, and to both agents given to- vivo studies in which compounds that block a-adrenergic gether. Uterine blood flow (UBF) increasedsignificantly after receptors were used. Although in some studies (5, 6) E2 administration, from 20 & 7 to 233 t 37 (SE) ml/min. In treatment with a-blocking agents was followed by uterine contrast, phentolamine had no detectable effect on UBF or on vasodilation similar to that produced by estrogen, this the UBF response E2 when both were given http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Heart and Circulatory Physiology The American Physiological Society

Role of alpha-receptors in estrogen-induced vasodilation in nonpregnant sheep

Loading next page...
 
/lp/the-american-physiological-society/role-of-alpha-receptors-in-estrogen-induced-vasodilation-in-She1zd11Ok

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 1985 the American Physiological Society
ISSN
0363-6135
eISSN
1522-1539
Publisher site
See Article on Publisher Site

Abstract

attractive. However, only equivocal support for such a mechanism presently exists. For example, decreased tisH344,1985.-Estradiol-17p (E2) producesvasodilation in sev- sue concentrations of a-receptors have been reported in eral systemicvascular beds,but most extensively in the non- the presence of estrogen (8,X), but in several studies an pregnant uterus. It has been postulated that E2 induces this increase in a-receptors has been noted (14, 15, 20). vasodilation via blockade of vascular cu-adrenergic receptors. Furthermore, estrogen treatment has been shown both This hypothesis was tested in six chronically instrumented, nonpregnant sheep by comparing the systemic and uterine to increase (3) and decrease (10) tissue levels of cateresults have also come from in hemodynamicresponses intravenous E2, to an cu-adrenergic cholamines. Conflicting to receptor blocker, phentolamine, and to both agents given to- vivo studies in which compounds that block a-adrenergic gether. Uterine blood flow (UBF) increasedsignificantly after receptors were used. Although in some studies (5, 6) E2 administration, from 20 & 7 to 233 t 37 (SE) ml/min. In treatment with a-blocking agents was followed by uterine contrast, phentolamine had no detectable effect on UBF or on vasodilation similar to that produced by estrogen, this the UBF response E2 when both were given

Journal

AJP - Heart and Circulatory PhysiologyThe American Physiological Society

Published: Mar 1, 1985

There are no references for this article.